Here's what I can summarize and share on SG Medical.
It's on Catalist, with business split into 4 clusters: eye, aesthetics, sports and critical illness. The eye cluster contributed some 78% of profits for 2009. However the same eye cluster suffered slower sales in FY2009 and contributed in part to the Exec Chairman and CEO foregoing their 2 months contractual bonus. Results have since improved in the following 6 months.
In Oct 2010 it announced that it had entered into an MOU to form a JV (75% holding) in Mongolia and open a 50 bed tertiary hospital there.
Opinion: I do not see much synergy in its business and while one would have thought that aesthetics would make its money, it does not. We are still basically talking about profitability rather than about a business with a strong niche and product.
It's on Catalist, with business split into 4 clusters: eye, aesthetics, sports and critical illness. The eye cluster contributed some 78% of profits for 2009. However the same eye cluster suffered slower sales in FY2009 and contributed in part to the Exec Chairman and CEO foregoing their 2 months contractual bonus. Results have since improved in the following 6 months.
In Oct 2010 it announced that it had entered into an MOU to form a JV (75% holding) in Mongolia and open a 50 bed tertiary hospital there.
Opinion: I do not see much synergy in its business and while one would have thought that aesthetics would make its money, it does not. We are still basically talking about profitability rather than about a business with a strong niche and product.
Homepage
